Intravenous Delivery of the Toll-Like Receptor 7 Agonist SC1 Confers Tumor Control by Inducing a CD8+ T Cell Response
OncoImmunology - United States
doi 10.1080/2162402x.2019.1601480
Full Text
Open PDFAbstract
Available in full text
Date
April 19, 2019
Authors
Publisher
Informa UK Limited